The global single nucleotide polymorphism (SNP) genotyping market size was valued at USD 7.24 billion in 2025 and is predicted to hit around USD 19.48 billion by 2034, rising at a 11.7% CAGR, a study ...
Cardiovascular disease (CVD) is a major health problem and is one of the leading causes of death in industrialized countries. 1, 2 It is a multifactorial complex disease, composed of several vascular ...
The International Society for Sexual Medicine (2008) operationally defined lifelong premature ejaculation (LPE) as the occurrence of an intra-vaginal ejaculation latency time (IELT) within ⩽1 min ...
In this issue, Gryshchenko et al 1 report that a known single nucleotide polymorphism (SNP) in the promoter region of MDM2 is associated with treatment-free and overall survival in chronic lymphocytic ...
FDA researchers present case studies using soft sensors to predict critical quality attributes and monitor crystallinity and ...
Phase I Trial of Yttrium-90—Labeled Anti—Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Androgen-Independent Prostate Cancer In the future, we will invariably see much more on ...
1982 The Human Polymorphism Study Center, the first academic institution to propose the systematic study of polymorphisms, is founded in Paris. Its primary objective: to make an inventory of all ...
Identifying polymorphs is a crucial part of the drug-development process as researchers forward select methods to improve detection. Screening and detecting polymorphism when developing and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results